Top Markets
Coin of the day
Inari Medical, Inc. Inari Medical, Inc.

Inari Medical, Inc.

NARI
Pozycja w akcjach #3844
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
Cena akcji
$79.97
Ostatnia synchronizacja: 2025-02-19
Kapitalizacja rynkowa
$4.57B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Inari Medical, Inc. (NARI)

Kategoria

Zyski dla Inari Medical, Inc. (NARI)
Zyski w Sep 2024 TTM: $-53.36M
Według najnowszych raportów finansowych Inari Medical, Inc., obecny zysk firmy wynosi $-53.36M. W roku 2022 firma osiągnęła zysk w wysokości $-26.19M, spadek w porównaniu do zysku z roku 2021, który wynosił $10.69M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Inari Medical, Inc. od 2018 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-53.36M -1,356.64%
2023 $4.25M -116.22%
2022 $-26.19M -345.06%
2021 $10.69M -22.51%
2020 $13.79M -1,256.97%
2019 $-1.19M -88.26%
2018 $-10.15M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$7.51B -14,176.88%
US
$5.15B -9,748.22%
US
$5.56B -10,526.00%
IE
$3.86B -7,336.16%
US
- -
DE